v3.26.1
Stockholders' Equity (Deficit) (Tables)
3 Months Ended
Mar. 31, 2026
Stockholders' Equity (Deficit)  
Schedule of stock-based compensation expense

For the Three Months Ended

  ​ ​ ​

March 31, 

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

38,934

$

64,677

Selling, general and administrative

1,765,551

214,951

$

1,804,485

$

279,628

Schedule of the warrant activity and related information The following table presents information related to warrants as of March 31, 2026:

Warrants Outstanding

Warants Exercisable

Weighted

Outstanding

Average

Exercisable

Exercise

  ​ ​ ​

Number of

  ​ ​ ​

Remaining Life

  ​ ​ ​

Number of

Price

Warrants

In Years

Warrants

$

3.2500

32,615,381

4.2

32,615,381

$

4.0000

 

350,000

 

4.2

 

350,000

$

5.2720

 

394,234

 

4.4

 

394,234

$

8.6080

 

302,045

 

3.8

 

302,045

$

197.5680

 

108,696

 

3.8

 

108,696

$

217.9200

 

49,280

 

3.8

 

49,280

$

380.8000

 

1,149

 

5.1

 

1,149

 

33,820,785

 

4.2

 

33,820,785

Summary of restricted stock units ("RSUs") activity

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

Average

Number of

Grant Date

  ​ ​ ​

RSUs

  ​ ​ ​

Price

RSUs non-vested January 1, 2026

 

1,545,000

$

6.63

Granted

 

111,131

 

3.46

Vested

 

(147,804)

 

2.45

Delivered

(55,277)

9.58

RSUs non-vested March 31, 2026

 

1,453,050

$

6.70

Vested RSUs undelivered March 31, 2026

 

432,355

$

4.45